10.1007_s00441-019-02996-x.pdf (5.29 MB)
0/0

The use of PRP injections in the management of knee osteoarthritis

Download (5.29 MB)
journal contribution
posted on 21.02.2019 by Brendan O’Connell, Nick Wragg, Sammy Wilson
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response and progressive deterioration of the joint architecture that commonly affects the knee and/or hip joints. It is a major world public health problem and is predicted to increase rapidly with an ageing population and escalating rate of obesity. Autologous blood-derived products possess much promise in the repair and regeneration of tissue and have important roles in inflammation, angiogenesis, cell migration and metabolism in pathological conditions, including OA. Utilising platelet-rich plasma (PRP) to treat tendon, ligament and skeletal muscle has shown variable results across many studies with the current evidence base for the efficacy of PRP in treating sports injuries remaining inconclusive. More uniformly positive results have been observed by various studies for PRP in OA knee in comparison to hyaluronic acid, other intra-articular injections and placebo than in other musculoskeletal tissue. However, methodological concerns as well as satisfactory PRP product classification prevent the true characterisation of this treatment. Thus, further research is required to investigate how leukocyte inclusion, activation and platelet concentration affect therapeutic efficacy. Furthermore, the optimisation of timing, dosage, volume, frequency and rehabilitation strategies need to be ascertained. For knee OA management, these concerns must be addressed before this promising treatment can be widely implemented.

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Cell and Tissue Research

Volume

376

Issue

2

Pages

143-152

Citation

O'CONNELL, B., WRAGG, N.M. and WILSON, S.L., 2019. The use of PRP injections in the management of knee osteoarthritis. Cell and Tissue Research, 376(2), pp.143–152

Publisher

Springer (© The Authors)

Version

VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/ by/4.0/

Acceptance date

11/01/2019

Publication date

2019-02-13

Notes

This is an Open Access Article. It is published by Springer under the Creative Commons Attribution 4.0 Unported Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/

ISSN

0302-766X

eISSN

1432-0878

Language

en

Licence

Exports

Logo branding

Licence

Exports